Published in Proc Natl Acad Sci U S A on December 19, 2005
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest (2008) 2.10
Endothelial cell heterogeneity. Cold Spring Harb Perspect Med (2012) 1.88
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J (2009) 1.79
Towards a holistic, yet gene-centered analysis of gene expression profiles: a case study of human lung cancers. J Biomed Biotechnol (2006) 1.22
Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol (2009) 1.11
Vasculogenesis in infantile hemangioma. Angiogenesis (2009) 1.11
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells (2015) 1.05
Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol (2014) 0.96
Biology of infantile hemangioma. Front Surg (2014) 0.94
A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis (2010) 0.92
Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features. Skeletal Radiol (2012) 0.88
Infantile hemangiomas: A review. Saudi J Ophthalmol (2012) 0.85
Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr (2009) 0.85
Lack of nAChR activity depresses cochlear maturation and up-regulates GABA system components: temporal profiling of gene expression in alpha9 null mice. PLoS One (2010) 0.84
A potential role for notch signaling in the pathogenesis and regulation of hemangiomas. J Craniofac Surg (2009) 0.83
E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol (2012) 0.83
Hypothesis: the metastatic niche theory can elucidate infantile hemangioma development. J Cutan Pathol (2010) 0.81
Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells. Vasc Cell (2013) 0.80
Hypothyroidism due to hepatic hemangioendothelioma: a case report. J Clin Res Pediatr Endocrinol (2010) 0.79
Vascular tumors. Semin Plast Surg (2014) 0.76
Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. JCI Insight (2016) 0.76
Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangioma. BMC Med Genet (2016) 0.75
Beta-blockers as therapy for infantile hemangiomas. Semin Plast Surg (2014) 0.75
Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell. Sci Rep (2016) 0.75
Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I). Eur J Pediatr (2014) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A (2001) 19.30
Gene regulation and DNA damage in the ageing human brain. Nature (2004) 9.01
Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res (2001) 6.78
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
Molecular portraits and the family tree of cancer. Nat Genet (2002) 3.28
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics (2003) 2.92
Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A (2003) 2.87
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol (2000) 2.86
Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am (1993) 2.69
Vascular anomalies. Curr Probl Surg (2000) 2.60
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol (2001) 1.77
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med (2000) 1.72
Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab (2003) 1.58
Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A (2002) 1.56
Mouse placenta is a major hematopoietic organ. Development (2003) 1.54
Endothelial progenitor cells in infantile hemangioma. Blood (2003) 1.50
Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer (2002) 1.49
Strawberry hemangioma in preterm infants. Pediatr Dermatol (1986) 1.44
Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics (2003) 1.39
Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc Natl Acad Sci U S A (2003) 1.29
Molecular classification and molecular genetics of human lung cancers. Semin Oncol (2004) 1.26
Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med (2002) 1.26
Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements. J Cutan Pathol (1993) 1.14
Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol (2004) 1.10
Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet (2000) 1.07
Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. Pharmacogenomics (2001) 1.05
An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn (1995) 1.00
Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma. Lymphat Res Biol (2003) 0.95
Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol (2003) 0.94
Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. Placenta (2005) 0.93
Are infantile hemangiomas of placental origin? Ophthalmology (2002) 0.93
Cellular hemangiomas ("hemangioendotheliomas") in infants. Light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol (1991) 0.89
Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol (2004) 0.87
Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab (1997) 0.85
Isolation and cultivation of endothelial cells derived from human placenta. Eur J Cell Biol (1996) 0.83
Erythroid-specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood. Prenat Diagn (1993) 0.80
Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage. Rocz Akad Med Bialymst (1997) 0.77
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet (2003) 13.33
STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature (2005) 8.96
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature (2008) 7.60
Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A (2006) 7.26
Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature (2006) 7.22
Clinical translation of angiogenesis inhibitors. Nat Rev Cancer (2002) 6.58
Reconstituting organ-level lung functions on a chip. Science (2010) 5.75
Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol (2009) 5.41
Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA (2006) 5.10
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst (2006) 4.44
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14
Viscoelastic retraction of single living stress fibers and its impact on cell shape, cytoskeletal organization, and extracellular matrix mechanics. Biophys J (2006) 4.06
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett (2005) 3.90
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst (2002) 3.77
Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72
Microtubules can bear enhanced compressive loads in living cells because of lateral reinforcement. J Cell Biol (2006) 3.63
Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin Cancer Res (2007) 3.53
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development (2004) 3.45
Directional control of lamellipodia extension by constraining cell shape and orienting cell tractional forces. FASEB J (2002) 3.45
A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature (2009) 3.44
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood (2007) 3.38
Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science (2012) 3.33
Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation (2008) 3.33
Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet (2008) 3.29
Mechanical control of tissue and organ development. Development (2010) 3.18
Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet (2012) 3.13
ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet (2003) 3.12
Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle (2006) 3.10
Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A (2003) 3.10
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol (2005) 3.07
Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood (2008) 3.05
Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci (2006) 2.98
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics (2003) 2.92
Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation (2009) 2.83
From 3D cell culture to organs-on-chips. Trends Cell Biol (2011) 2.83
Venous malformations of skeletal muscle. Plast Reconstr Surg (2002) 2.79
Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3. J Biol Chem (2008) 2.75
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development (2005) 2.73
Cell shape provides global control of focal adhesion assembly. Biochem Biophys Res Commun (2003) 2.71
Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet (2009) 2.69
Mechanical forces alter zyxin unbinding kinetics within focal adhesions of living cells. J Cell Physiol (2006) 2.62
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60
Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet (2003) 2.56
A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med (2012) 2.52
Platelets actively sequester angiogenesis regulators. Blood (2008) 2.47
Effect of an imaging protocol on clinical outcomes among pediatric patients with appendicitis. Pediatrics (2002) 2.47
Micropatterning tractional forces in living cells. Cell Motil Cytoskeleton (2002) 2.45
High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol (2005) 2.44
Cell tension, matrix mechanics, and cancer development. Cancer Cell (2005) 2.42
Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE (2002) 2.36
Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip (2012) 2.36
Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet (2005) 2.33
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest (2002) 2.31
Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J (2003) 2.30
Current management of hemangiomas and vascular malformations. Clin Plast Surg (2005) 2.27
Nanomagnetic actuation of receptor-mediated signal transduction. Nat Nanotechnol (2007) 2.22
Microengineered physiological biomimicry: organs-on-chips. Lab Chip (2012) 2.21
Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20
Intramuscular capillary-type hemangioma: radiologic-pathologic correlation. Pediatr Radiol (2014) 2.16
Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med (2010) 2.16
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest (2012) 2.15
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol (2005) 2.14
Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol (2002) 2.14
Genome wide association studies for milk production traits in Chinese Holstein population. PLoS One (2010) 2.13
Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension. Dev Dyn (2005) 2.13
Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol (2002) 2.13
Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med (2010) 2.11
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol (2002) 2.10
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest (2008) 2.10
RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev (2005) 2.10
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
Intracellular stress tomography reveals stress focusing and structural anisotropy in cytoskeleton of living cells. Am J Physiol Cell Physiol (2003) 2.09
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A (2006) 2.09
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res (2007) 2.07
A clinical decision rule to identify children at low risk for appendicitis. Pediatrics (2005) 2.06
Prostanoids in health and disease. J Lipid Res (2008) 2.06
Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology (2013) 2.06
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res (2009) 2.04
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest (2006) 2.03
Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest (2004) 2.03
The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat (2010) 2.03
Validity and reliability of craniofacial anthropometric measurement of 3D digital photogrammetric images. Cleft Palate Craniofac J (2008) 2.02
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat (2008) 2.00
Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem (2004) 1.98